• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Coverage

Latest content

Antti Siltanen

Analyst

Antti Siltanen portrait

Coverage

Herantis PharmaNexstimFaron PharmaceuticalsNightingale HealthBioretecAiforia TechnologiesBiohitOrionModulight

Latest content

ShowingAll content types

Farons BEXMAB-opdatering gav yderligere information om responsvarigheden

Analyst Comment 16.06.2026, 06.24 by Antti Siltanen
Faron Pharmaceuticals

Significant one-time order for Nexstim

Analyst Comment 12.06.2026, 08.28 by Antti Siltanen
Nexstim

Aiforia expands to nine hospitals in Spain

Analyst Comment 12.06.2026, 08.26 by Antti Siltanen
Aiforia Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Nightingale: We factored the project delay into our estimates

Research 12.06.2026, 09.20 by Antti Siltanen, Antti Luiro
Nightingale Health

Nightingale's profit warning: Project delay shifts revenue to next year

Analyst Comment 09.06.2026, 08.40 by Antti Siltanen
Nightingale Health

Nexstim received a new sales authorization for the NBS 6 system in Australia

Analyst Comment 04.06.2026, 07.48 by Antti Siltanen
Nexstim

Nightingale: Nightingale sings to a deaf market

Research 04.06.2026, 08.36 by Antti Siltanen
Nightingale Health

Herantis: Clarity on efficacy study details

Research 03.06.2026, 10.21 by Antti Siltanen
Herantis Pharma

Bioretec seeks additional savings through change negotiations

Analyst Comment 02.06.2026, 09.18 by Antti Siltanen
Bioretec

Orion: Første resultater fra lægemiddelkandidat ODM-212

Analyst Comment 01.06.2026, 07.34 by Antti Siltanen
Orion